Mini Review - Clinical Schizophrenia & Related Psychoses ( 2024) Volume 0, Issue 0
Factor Structure of Posttraumatic Stress Disorder (PTSD) in Persons with Serious Mental Illness
Weili Lu1*, Kim T Mueser2, Yuane Jia1, Philip T Yanos3, Amanda Siriram1, Deanna Bullock1, Ke Wang1, Steven M Silverstein4, Jennifer Gottlieb5, Krista Rogers3, Pouya G Aftab1 and Stanley D Rosenberg62Department of Psychiatric Rehabilitation, Boston University, Boston, USA
3Department of Psychology, City University of New York, New York, USA
4Department of Psychiatry, University of Rochester Medical Center, New York, USA
5Department of Psychiatry, Harvard Medical School, Boston, USA
6Department of Psychiatry, Dartmouth Geisel School of Medicine, New Hampshire, USA
Weili Lu, Department of Psychiatric Rehabilitation and Counseling Professions, Rutgers Univeristy, New Jersey, USA, Email: luwe1@shp.rutgers.edu
Received: 18-Jun-2024, Manuscript No. CSRP-24-139292; Editor assigned: 21-Jun-2024, Pre QC No. CSRP-24-139292 (PQ); Reviewed: 08-Jul-2024, QC No. CSRP-24-139292; Revised: 16-Jul-2024, Manuscript No. CSRP-24-139292 (R); Published: 24-Jul-2024, DOI: 10.3371/CSRP.AMOS.100003
Abstract
Posttraumatic Stress Disorder (PTSD) is highly prevalent and contributes to worsened impairment among individuals with serious mental illness (SMI; e.g., schizophrenia, schizoaffective disorder, bipolar disorder, treatment refractory major depressive disorder). However, previous research has not examined the factor structure of PTSD symptoms in SMI populations. This review summarizes a published article evaluating the factor structure of PCL in two large SMI samples (N=11425; n=842 in study 1, n=583 in study 2). The latest edition of the DSM-5 4-aspect framework was shown to be the most appropriate one for PTSD amongst individuals suffering from SMI, exhibiting consistent measurement results across ethnic background, classifications of diagnosis, and generations. The review further discusses the suitability of DSM-5 4-factor model of PTSD among people with SMI, as well as future directions for PTSD research among this population.
Keywords
PTSD • Serious Mental Illness (SMI) • Factor structure • PTSD checklist • Trauma assessment • Schizophrenia
Abbreviations
SABIC: Sample Size Adjusted Bayesian Information Criterion; TLI: Tucker Lewis Index; CFI: Comparative Fit Index; SRMR: Standardized Root Mean Square Residual; RMSEA: Root-Mean Square Error of Approximation
Introduction
Research has supported the high prevalence of comorbid Posttraumatic Stress Disorder (PTSD) in person with serious mental illnesses (SMI, i.e., schizophrenia, bipolar disorder, and treatment refractory Major Depressive Disorder (MDD) [1]. For example, one review found that PTSD prevalence rates in schizophrenia ranged between 20%-30% [2]. Previous studies have also highlighted the association with Adverse Childhood Experiences (ACEs) with SMI development, as well as increased rates of comorbid PTSD among individuals with SMI compared to the general population.
Symptoms of PTSD could be hidden or under-detected in SMI due to SMI-associated illnesses and deficits. Identification of schizophrenia/ schizoaffective illness or bipolar disorder contributed to lower PTSD record preservation [3]. Examples of barriers in recognizing PTSD symptoms in SMI include distinguishing between paranoid delusions in psychosis from the chronic mistrust common in PTSD, or distinguishing between mania symptoms such as irritability, risk-taking behaviours, and decreased need for sleep from anger outbursts, reckless or self-destructive behaviours, and sleep difficulties in PTSD. Considering the difficulty in diagnosing signs of PTSD in people with SMI, physicians should adopt PTSD screening techniques for patients in order to improve identification. To educate the medical community, it is vital to investigate the PCL component architecture among people with SMI.
The PTSD Checklist is commonly used as a PSTD screening measure [4]. The factor structure of the PCL has been assessed by various Confirmatory Factor Analyses (CFAs) in non-SMI samples such as veterans, college students, substance dependent clients and firefighters. Six of the eleven investigations accepted Elhai's 5-factor Dysphoric Arousal as the greatest match, three accepted King's Diagnostic and Statistical Manual of Mental Disorders (DSM-5) 4-factor model as the second best fit, and two supported Simms' 5-factor Dysphoria model. The DSM-IV 3-factor model includes re-experiencing, avoidance and over-arousal; the King's 4-factor Numbing model (aka DSM-5 model) involves all three of those variables in the inclusion of alleviating factor; the Simms' 4-factor Dysphoria model also incorporates those three factors with the addition of dysphoria; the DSM-5 4-factor model proposed symptom clusters of re-experiencing, avoidance, negative cognitions/mood, and over-arousal; Elhai's 5-factor model suggested factor. However, these previous CFA studies have not examined the factor structure of the Posttraumatic Checklist (PCL) utilizing a large SMI sample, which could be informative both clinically and for research.
Literature Review
This review summarizes a published article evaluating the factor structure of PTSD symptoms measured with the PCL in two large samples of people with SMI (n=842 in study 1, n=583 in study 2) [5]. It investigated whether the PCL factor structure in the SMI population is similar to the factor structures reported in other populations [6]. One previous study, using the PCL with a veteran sample, supported Elhai’s 5-factor and DSM-5 4-factor models, while another study, using the PTSD Checklist for the DSM-5 (PCL-5) with an SMI sample, supported the DSM-5 4-factor model and the 7-factor model of PTSD [7]. Based on earlier findings from 10 reviewed studies, the hypothesis anticipated that the DSM-5 4-factor model would have the best fit, while Elhai’s 5-factor, Simms’ Dysphoria 4-factor, and the DSM-IV 3-factor models would each have adequate fit [5].
Participants in Study 1 were drawn from a larger investigation of patients with SMI receiving treatment through public mental health systems in four U.S. states. Among the 1114 people in the larger study, 842 participants had PCL data. Of these, 50.8% had schizophrenia, 21.7% had schizoaffective disorder, 25.3% had bipolar disorder, and 8.3% had recurrent MDD. Study 2 included data from 583 participants with SMI diagnoses who were screened for PTSD in a large public mental health outpatient system in the US. The breakdown of participants was as follows: 11.1% had schizophrenia, 20.6% had schizoaffective disorder, 34.7% had bipolar disorder, and 33.9% had major MDD [5]. All participants met the state criteria for SMI. Participants in both studies were racially and ethnically diverse (45.7% African American; 40.6% Caucasian; 6.5% Hispanic; 3.5% American Indian; 0.6% Asian; 3.1% other) (Table 1).
Demographics/Clinical characteristics | Study 1-5 Site (n=842) | Study 2-NJ (n=583) |
Total (N=1425) |
|||||
---|---|---|---|---|---|---|---|---|
Gender |
n | % | n | % | n | % | χ2 107 | P <0.001 |
Male |
310 | 63 | 206 | 35.3 | 738 | 51.8 | ||
Female |
310 | 37 | 377 | 64.7 | 687 | 48.2 | ||
Race/Ethnicity |
3.94 |
<0.001 |
||||||
African American |
388 | 46 | 262 | 44.9 | 650 | 45.7 | ||
Caucasian |
379 | 45 | 199 | 34.1 | 578 | 40.6 | ||
Hispanic |
24 | 2.9 | 68 | 11.7 | 92 | 7 | ||
American Indian |
49 | 5.8 | 1 | 0.2 | 50 | 4 | ||
Asian |
0 | 0 | 8 | 1 | 8 | 1 | ||
Other |
0 | 0 | 44 | 8 | 44 | 3 | ||
Missing |
0 | 0 | 1 | 0 | 1 | 0 | ||
Married |
4 |
0 |
||||||
Yes |
93 | 11 | 46 | 8 | 139 | 9.8 | ||
No |
746 | 89 | 536 | 91.9 | 1282 | 90 | ||
Missing |
3 | 0.4 | 1 | 0 | 4 | 0 | ||
Education |
37.06 | <0.001 | ||||||
Less than HS |
310 | 37 | 153 | 463 | 463 | 32.5 | ||
HS |
242 | 29 | 28.7 | 42.2 | 488 | 34.2 | ||
Beyond HS |
285 | 34 | 173 | 29.7 | 458 | 32.1 | ||
Missing |
5 | 0.6 | 11 | 2 | 16 | 1 | ||
Primary diagnosis |
363.49 |
<0.001 |
||||||
Schizophrenia |
428 | 51 | 65 | 11.1 | 493 | 34.6 | ||
Schizoaffective |
183 | 22 | 120 | 20.6 | 303 | 21.3 | ||
Bipolar I without psychotic |
45 | 13 | 92 | 6.0 | 200 | 14.0 | ||
Bipolar I with psychotic |
45 | 5.3 | 35 | 6 | 80 | 6 | ||
Bipolar II |
6 | 0.7 | 33 | 6 | 39 | 3 | ||
Bipolar NOS |
2 | 0.2 | 42 | 7 | 44 | 3 | ||
MDD recur. w/o psychotic |
49 | 5.8 | 150 | 25.7 | 199 | 14.0 | ||
MDD recur. w/ psychotic |
21 | 2.5 | 46 | 8 | 67 | 5 | ||
Secondary diagnosis |
547.71 |
<0.001 |
||||||
Borderline personality disorder |
7 | 0.8 | 22 | 7 | 29 | 3 | ||
PTSD |
14 | 1.7 | 51 | 16 | 65 | 6 | ||
Substance use disorder |
99 | 12 | 89 | 27.9 | 188 | 16.3 | ||
Alcohol use disorder |
143 | 17 | 56 | 17.6 | 199 | 17.2 | ||
Personality disorder other than BPD |
19 | 2.3 | 9 | 3 | 28 | 2 | ||
PCL |
234.10 |
<0.001 |
||||||
< 45 |
533 | 63 | 129 | 22.2 | 662 | 46.5 | ||
> 45 |
309 | 37 | 453 | 77.8 | 762 | 53.5 | ||
|
M | SD | M | SD | M | SD | t | P |
Age* |
41.93 | 10 | 41 | 11.36 | 41.53 | 10.60 | 2 | 0.1 |
PCL sum |
39.11 | 16 | 55 | 16.59 | 45.75 | 18.1 | -18.4 | <0.001 |
Note. Age range: 19-80 for study 1, 18-70 for study 2.
There were also notable differences among participants. In terms of gender, Study 1 had a large percentage (63.2%) of men compared to Study 2 (35.3%). Moreover, schizophrenia/schizoaffective disorder was more common than mood disorders in Study 1 (72.5% vs 27.5%), while mood disorders were more common than schizophrenia/schizoaffective disorder in Study 2 (31.7% vs 69.3%). Finally, while PTSD levels varied among participants in Study 1, 78% of participants in Study 2 had a PCL score of 45 or higher, indicating probable PTSD. CFAs were conducted with Mplus 8.7 to assess how well the four models fit the data across the combined sample, the Study 1 sample, study 2 sample and schizophrenia, bipolar, and MDD samples separately (Table 2) [5].
â?¯ Total Sample (N=1425)
|
χ2
|
df
|
χ2/df
|
P
|
CFI
|
TLI
|
RMSEA
|
SRMR
|
SABIC
|
---|---|---|---|---|---|---|---|---|---|
DSM IV 3-factor
|
643.390
|
116
|
5.546
|
<0.001
|
0.961
|
0.954
|
0.056
|
0.030
|
75204.426
|
DSM-5 4-factor
|
452.280
|
113
|
4.002
|
<0.001
|
0.975
|
0.970
|
0.046
|
0.022
|
75025.570
|
Simms 4-factor
|
459.216
|
113
|
4.064
|
<0.001
|
0.974
|
0.969
|
0.046
|
0.022
|
75032.511
|
Elhai 5-factor
|
448.507
|
109
|
4.115
|
<0.001
|
0.975
|
0.968
|
0.047
|
0.022
|
75038.143
|
Note: Model fit for total sample (N=1425): DSM5> Simms> 5-factor> 3-factor.
|
|||||||||
Study 1 (5-Site, n=842)
|
|||||||||
DSM IV 3-factor
|
402.439
|
116
|
3.469
|
<0.001
|
0.958
|
0.950
|
0.054
|
0.031
|
43123.073
|
DSM-5 4-factor
|
289.873
|
113
|
2.565
|
<0.001
|
0.974
|
0.969
|
0.043
|
0.024
|
43021.188
|
Simms 4-factor
|
289.087
|
113
|
2.558
|
<0.001
|
0.974
|
0.969
|
0.043
|
0.024
|
43020.401
|
Elhai 5-factor
|
model inadmissible; correlation>1 between two factors (anxious and dysphoric arousal)
|
||||||||
Note: Model fit for study 1 sample (5-Site, n=842): DSM5 ≈ Simms> 3-factor> 5-factor.
|
|||||||||
Study 2 (NJ, n=583)
|
|||||||||
DSM IV 3-factor
|
452.268
|
116
|
3.899
|
<0.001
|
0.930
|
0.918
|
0.071
|
0.044
|
31164.165
|
DSM-5 4-factor
|
356.162
|
113
|
3.152
|
<0.001
|
0.949
|
0.939
|
0.061
|
0.034
|
31077.640
|
Simms 4-factor
|
358.936
|
113
|
3.176
|
<0.001
|
0.949
|
0.938
|
0.061
|
0.033
|
31080.414
|
Elhai 5-factor
|
352.633
|
109
|
3.235
|
<0.001
|
0.949
|
0.937
|
0.062
|
0.033
|
31086.885
|
Note: Model fit for study 2 sample (NJ, n=583): DSM5>Simms>5-factor>3-factor.
|
|||||||||
Schizophrenia (n= 796)
|
|||||||||
DSM IV 3-factor
|
461.689
|
116
|
3.980
|
<0.001
|
0.949
|
0.941
|
0.061
|
0.034
|
41162.892
|
DSM-5 4-factor
|
320.055
|
113
|
2.832
|
<0.001
|
0.970
|
0.964
|
0.048
|
0.025
|
41031.771
|
Simms 4-factor
|
323.692
|
113
|
2.865
|
<0.001
|
0.969
|
0.963
|
0.048
|
0.025
|
41035.307
|
Elhai 5-factor
|
model inadmissible; correlation >1 between two factors (anxious arousal with dysphoric arousal)
|
||||||||
Note: Model fit for schizophrenia sample (n=796): DSM5>Simms>3-factor>5-factor.
|
|||||||||
Bipolar (n=363)
|
|||||||||
DSM IV 3-factor
|
244.535
|
116
|
2.108
|
<0.001
|
0.960
|
0.953
|
0.055
|
0.037
|
19745.545
|
DSM-5 4-factor
|
203.305
|
113
|
1.799
|
<0.001
|
0.972
|
0.966
|
0.047
|
0.034
|
19712.480
|
Simms 4-factor
|
215.113
|
113
|
1.904
|
<0.001
|
0.968
|
0.962
|
0.050
|
0.034
|
19724.288
|
Elhai 5-factor
|
202.192
|
109
|
1.855
|
<0.001
|
0.971
|
0.964
|
0.049
|
0.034
|
19722.255
|
Note: Model fit for bipolar sample (n=363): DSM5> 5-factor> Simms> 3 factor.
|
|||||||||
MDD (n=266)
|
|||||||||
DSM IV 3-factor
|
316.611
|
116
|
2.729
|
<0.001
|
0.922
|
0.908
|
0.081
|
0.050
|
13447.810
|
DSM-5 4-factor
|
236.466
|
113
|
2.093
|
<0.001
|
0.952
|
0.942
|
0.064
|
0.039
|
13374.904
|
Simms 4-factor
|
220.519
|
113
|
1.951
|
<0.001
|
0.958
|
0.950
|
0.060
|
0.037
|
13358.957
|
Elhai 5-factor
|
model inadmissible; correlation>1 between two factors (anxious arousal with dysphoric arousal)
|
||||||||
Note: Model fit for MDD sample (n=266): Simms> DSM5> 3-factor> 5-factor.
|
Multiple indicators were used to assess the model's quality of fit. The outcomes somewhat confirmed the hypothesis. The findings showed that while the DSM-5 4-factor model had the best overall fit, the Simms’ model was the next best fit. The results did not support Elhai’s 5-factor model, which displayed a poor fit for data in the schizophrenia sample, the MDD sample, and the Study 1 sample. It was noted, upon comparison fit indices across the various samples, that the DSM-5 model performed well compared to the DSM-IV and the Simms models. Furthermore, while PTSD symptoms in the overall SMI sample, and the schizophrenia and bipolar samples were best explained by DSM-5 4-factor model, Simms’s model did perform better in the MDD sample than the DSM-5 model, which suggests a need for further research focused on PCL for individuals with MDD.
Measurement invariance was evaluated using multi-group CFA across various groups: psychotic vs. nonpsychotic, gender (male vs. female), race (white vs. black), age (18-35 vs. 35+), and diagnostic categories (schizophrenia/schizoaffective vs. bipolar vs. MDD) for the best fitting DSM-5 model (Table 2). Among psychotic and nonpsychotic groups, the DSM-5 4-factor model showed configure uniformity and high fit. The DSM-5 4-factor model showed outstanding match among genders and ethnicities.
The factor loadings and inter correlations of the DSM-5 4-factor model across the total sample and each diagnostic group (Figure 1). Most items strongly fit their assigned factors, with loadings ranging from 0.70 to 0.86. However, three items-C3 (numbing), D1 (hypervigilance), and D4 (hypervigilance) exhibited weaker loadings, between 0.52 and 0.68. The inter correlations among the four factors showed acceptable to excellent fit for most groups. Additionally, the reliability of the intrusion, avoidance, numbing and hypervigilance subscales was acceptable to excellent for both the total sample and the diagnostic groups.
Figure 1. Factor pattern matrix and inter-factor correlation of DSM-5 4-factor model of PTSD for total sample (n=1425), schizophrenia/schizoaffective (n=796), bipolar disorder (n=363) and major depressive disorder (n=266). Note: Factor loadings and inter-factor-correlations are listed in the order of total sample/schizophrenia-schizoaffective/bipolar/major depressive disorder. Sample; CFI=0.97, 0.97, 0.97, 0.95 respectively.
Discussion
CFA was used to evaluate the fit of four PTSD models described in the prior literature in two distinct sets of people with SMI. These findings differ where the sample consisted of participants from the Million Veteran Program (MVP), which found that Elhai’s 5-factor model was the best fit model instead of the DSM-5 4-factor model [6]. In this study involving SMI populations, Elhai’s 5-factor model was inadmissible with the Study 1 sample, schizophrenia sample, and MDD sample, and did not achieve convergence. While [6] utilized veterans from all branches of the U.S. military, the current study focused on individuals with severe psychopathology and severe functional impairment due to SMI. However, findings are consistent with the evaluation of PTSD factor structure in SMI population using the PCL-5 [7] which supported the DSM-5 model.
Limitations from the present study should be noted. Data collected were from individuals with SMI receiving treatment through public mental health systems including community mental health centres and state psychiatric hospitals, thus findings may not generalize to other treatment settings or to those not in treatment. While the focus on the PCL for DSM-IV rather than the more updated PCL-5 for DSM-5 allowed for direct comparison with existing research of the factor structure of PTSD, It additionally excluded the study of the PCL-5's newer notion of PTS [8].
Conclusion
The findings support the use of DSM-5 model of PTSD among individuals with SMI, suggesting that similar diagnostic algorithms can be used for detecting and assessing PTSD in the SMI population. To gain a deeper and more current understanding of PTSD in individuals with SMI, future research should utilize the PCL-5 and incorporate clinician interviews, such as the Clinician Administered PTSD Scale for DSM-5 to evaluate the latest models of PTSD and examine the factor structure of PTSD among SMI populations. Future studies should further evaluate the utility of Elhai's 5-factor model among individuals with SMI, as well as examine the PTSD factor models in people with MDD and co-occurring PTSD. PTSD assessment leads to increased PTSD detection among individuals with SMI, which is essential for providing trauma-informed treatment access for this underserved population.
References
- Grubaugh, Anouk, Wilson Brown, Jessica Wojtalik and Ursula Myers, et al. Meta-Analysis of the Treatment of Posttraumatic Stress Disorder in Adults with Comorbid Severe Mental Illness. J Clin Psychiatry 82 (2021): 20r13584.
- Seow, Seng Esmond Lee, Clarissa Ong, Mithila Valli Mahesh and Vathsala Sagayadevan, et al. A Systematic Review on Comorbid Post-Traumatic Stress Disorder in Schizophrenia. Schizophr Res 176 (2016): 441–451.
- Lu, Weili, Jeganee Srijeyanthan, Kim Mueser and Philip Yanos, et al. Predictors of Undocumented Ptsd in Persons Using Public Mental Health Services. Psychiatry Res 317 (2022a): 114892.
- Blanchard, Edward, Jacqueline Jones-Alexander, Todd Buckley and Catherine Forneris. Psychometric Properties of the Ptsd Checklist (PCL). Behav Res Ther 34 (1996): 669-673.
- Lu, Weili, Kim Mueser, Philip Yanos and Yuane Jia, et al. Factor Structure of Posttraumatic Stress Disorder (Ptsd) in Persons with Serious Mental Illness. J Ment Health33 (2024): 1–10.
- Overstreet, Cassie, Daniel Levey, Hang Zhou and Kelly Harrington, et al. Factor Structure of the Posttraumatic Stress Disorder Checklist (Pcl-17) In 279,897 Million Veteran Program Participants. Psychiatry Res (2023) 319: 114994.
- Lu, Weili, Philip Yanos, William Waynor and Yuane Jia, et al. Psychometric Properties of Post-Traumatic Stress Disorder (Ptsd) Checklist For Dsm-5 in Persons with Serious Mental Illness. Eur J Psychotraumatol 13 (2022): 2038924. Crossref]
- Weathers, Frank, Litz, Brett Litz, Terence Keane and Brian Marx, et al. The ptsd checklist for dsm-5 (pcl-5). Scale available from the National Center for PTSD (2013) 10: 206.
Citation: Lu, Weili, Kim T Mueser, Philip T Yanos and Amanda Siriram, et al. "Factor Structure of Posttraumatic Stress Disorder (PTSD) in Persons with Serious Mental Illness." Clin Schizophr Relat Psychoses 18 (2024). DOI: 10.3371/CSRP.AMOS.100003
Copyright: �© 2024 Lu W, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.